Molecular mechanism of bone
metastasis development is extremely complex. It is determined by intrinsic properties of
cancer cells or cancer stem cells (CSCs) and intricate bone microenvironment. Therefore, molecular treatment strategies have been suggested to directly induce
cancer cells apoptosis and to target vascular and bone microenvironment as well, thus inhibiting vicious cycles established between osteoblasts/osteoclasts and metastatic
cancer cells.
Chemokine/
chemokine receptor pathway, adhesion molecules, and
proteinases are crucial for bone metastatic process, including migration, adhesion and invasion into bone, angiogenesis and cell proliferation, which could provide potential targets for prevention and treatment of bone
metastasis. Restoration of metastasis suppressor genes and
microRNAs inhibits bone
metastasis. Furthermore, targeting the bone marrow endothelium around
cancer cells by use of both antiangiogenic inhibitors and vascular disrupting agents is another promising and valid therapeutic approach. On the other hand, many
antitumor drugs/small molecules are limited in reaching
tumor site due to a very complex vasculature. Nanotechnology
aids in the targeted delivery of
antitumor drugs/small molecules. For severe bone lesion, multifunctional implants integrating with
antitumor drugs/small molecules and bone forming factors could be effective to reconstruct bone defects and to improve the quality of life in patients with bone
metastasis.